+44 (0)20 8817 5296info@tritrials.com

TRI to sponsor 8th annual Clinical Quality Oversight Forum

8th Annual Clinical Quality Oversight Forum With the adoption of ICH E6 (R2) by the EMA this month, and planned adoption for the FDA later this year, this event has never been more important or relevant to the way in which we conduct and oversee clinical trials. TRI’s CEO Duncan Hall will be presenting alongside Advanced Clinical’s SVP of…

Read More